Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Breast Neoplasms 17Lung Neoplasms 15Colonic Neoplasms 11Head and Neck Neoplasms 9Rectal Neoplasms 7Glioblastoma 5Prostatic Neoplasms 4Precancerous Conditions 4Mouth Neoplasms 4Esophageal Neoplasms 4Central Nervous System Neoplasms 4Adenomatous Polyposis Coli 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Neuroblastoma 3Neoplasms 3Liver Neoplasms 3Gliosarcoma 3Glioma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Smoking 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Celecoxib × Clear all
NCT02885974 2025-07-28

BLAST

Baylor College of Medicine

Phase 1 Completed
22 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00006124 2013-02-13

Celecoxib in Treating Patients With Bladder Cancer

National Cancer Institute (NCI)

Phase 2/3 Completed
152 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡